Paper39374239
Targeting of oxidized Macrophage Migration Inhibitory Factor (oxMIF) with antibody ON104 attenuates the severity of glomerulonephritis.
Ferhat M and 9 others. PLoS One, 2024. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Targeting of oxidized Macrophage Migration Inhibitory Factor (oxMIF) with antibody ON104 attenuates the severity of glomerulonephritis. Papers, record 39374239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39374239
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Targeting of oxidized Macrophage Migration Inhibitory Factor (oxMIF) with antibody ON104 attenuates the severity of glomerulonephritis.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Macrophage Migration-Inhibitory Factors | Major topic |
| Glomerulonephritis | Major topic |
| Animals | |
| Rats | |
| Humans | |
| Male | |
| Rats, Inbred WKY | |
| Disease Models, Animal | |
| Rabbits | |
| Macrophages | |
| Neutrophils | |
| Kidney | |
| Oxidation-Reduction | |
| Antibodies, Neutralizing |
Source PubMed
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32207164 | Phase I study of imalumab (BAX69), a fully human recombinant antioxidized macrophage migration inhibitory factor antibody in advanced solid tumours. | Br J Clin Pharmacol | 2020 | https://conductscience.org/library/papers/32207164 | PubMed |
| 2 | 31414920 | Macrophage migration inhibitory factor (MIF) as a therapeutic target for rheumatoid arthritis and systemic lupus erythematosus. | Expert Opin Ther Targets | 2019 | https://conductscience.org/library/papers/31414920 | PubMed |
| 3 | 22127710 | Dual effect of the macrophage migration inhibitory factor gene on the development and severity of human systemic lupus erythematosus. | Arthritis Rheum | 2011 | https://conductscience.org/library/papers/22127710 | PubMed |
| 4 | 10435873 | Development of scarring and renal failure in a rat model of crescentic glomerulonephritis. | Nephrol Dial Transplant | 1999 | https://conductscience.org/library/papers/10435873 | PubMed |
| 5 | 30358918 | MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor as a Possible Indicator of Response to Therapy in Membranous Nephropathy. | Proteomics Clin Appl | 2019 | https://conductscience.org/library/papers/30358918 | PubMed |
| 6 | 27425855 | The incidence, prevalence, and outcomes of glomerulonephritis derived from a large retrospective analysis. | Kidney Int | 2016 | https://conductscience.org/library/papers/27425855 | PubMed |
| 7 | 8988336 | Identification and immunohistochemical localization of macrophage migration inhibitory factor in human kidney. | Biochem Mol Biol Int | 1996 | https://conductscience.org/library/papers/8988336 | PubMed |
| 8 | 26611548 | Corticosteroids: Mechanisms of Action in Health and Disease. | Rheum Dis Clin North Am | 2016 | https://conductscience.org/library/papers/26611548 | PubMed |
| 9 | 26858715 | Macrophage Migration Inhibitory Factor in Clinical Kidney Disease. | Front Immunol | 2016 | https://conductscience.org/library/papers/26858715 | PubMed |
| 10 | 17890747 | Glomerular glucocorticoid receptor expression is reduced in late responders to steroids in adult-onset minimal change disease. | Nephrol Dial Transplant | 2008 | https://conductscience.org/library/papers/17890747 | PubMed |
| 11 | 17314328 | Inhibition of p38 mitogen-activated protein kinase is effective in the treatment of experimental crescentic glomerulonephritis and suppresses monocyte chemoattractant protein-1 but not IL-1beta or IL-6. | J Am Soc Nephrol | 2007 | https://conductscience.org/library/papers/17314328 | PubMed |
| 12 | 29475991 | Glucocorticoids in the Treatment of Glomerular Diseases: Pitfalls and Pearls. | Clin J Am Soc Nephrol | 2018 | https://conductscience.org/library/papers/29475991 | PubMed |
| 13 | 35091838 | Macrophage migration inhibitory factor family proteins are multitasking cytokines in tissue injury. | Cell Mol Life Sci | 2022 | https://conductscience.org/library/papers/35091838 | PubMed |
| 14 | 32132388 | The glomerular crescent: triggers, evolution, resolution, and implications for therapy. | Curr Opin Nephrol Hypertens | 2020 | https://conductscience.org/library/papers/32132388 | PubMed |
| 15 | 37579967 | The newly engineered monoclonal antibody ON104, targeting the oxidized Macrophage Migration Inhibitory Factor (oxMIF), ameliorates clinical and histopathological signs of collagen-induced arthritis. | Eur J Pharmacol | 2023 | https://conductscience.org/library/papers/37579967 | PubMed |
| 16 | 36180072 | OxMIF: a druggable isoform of macrophage migration inhibitory factor in cancer and inflammatory diseases. | J Immunother Cancer | 2022 | https://conductscience.org/library/papers/36180072 | PubMed |
| 17 | 27636991 | Oxidized macrophage migration inhibitory factor is a potential new tissue marker and drug target in cancer. | Oncotarget | 2016 | https://conductscience.org/library/papers/27636991 | PubMed |
| 18 | 30241958 | MIF Matters: The Macrophage Migration Inhibitory Factor and Kidney Injury. | Am J Kidney Dis | 2019 | https://conductscience.org/library/papers/30241958 | PubMed |
| 19 | 11792756 | Urine macrophage migration inhibitory factor reflects the severity of renal injury in human glomerulonephritis. | J Am Soc Nephrol | 2002 | https://conductscience.org/library/papers/11792756 | PubMed |
| 20 | 31608058 | MiRNA Regulation of MIF in SLE and Attenuation of Murine Lupus Nephritis With miR-654. | Front Immunol | 2019 | https://conductscience.org/library/papers/31608058 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42465767 | Macrophage migration inhibitory factor in atrial fibrillation. | Front Immunol | 2026 | https://conductscience.org/library/papers/42465767 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39374239
GET https://conductscience.org/api/papers/v1/39374239/references?page=2